Largest segment driving the growth of High End Cellomics Market |...

Largest segment driving the growth of High End Cellomics Market

Veröffentlicht 2023-11-27 13:36:23

The global High End Cellomics Market is estimated to be valued at US$ 3.9 Bn or Mn in 2023 and is expected to exhibit a CAGR of 12 % over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

SWOT Analysis

· Strength: - Growing research in genomics, proteomics and biomedical sciences is driving demand. Advances like single cell analysis are creating new opportunities.

· Weakness: - High setup and maintenance costs of instruments limits adoption among small labs and research institutes.

· Opportunity: - Emerging markets in Asia Pacific and Latin America are expected to boost the market due to growing R&D spending in healthcare and life sciences sectors.

· Threats: - Threat from open source equipment and DIY protocols developed by academic research groups. Intense competition among existing players.

Key Takeaways: -

The Global High End Cellomics Market Growth is expected to witness high, exhibiting CAGR of 12% over the forecast period, due to increasing R&D investments in genomics, proteomics and biomedical research globally.

Regional analysis: - North America dominates the market currently due to presence of major players and availability of funding for research activities from government and private sector. Asia Pacific is expected to be the fastest growing region due to rising focus on healthcare and biomedical sciences in countries like China and India.

Key players operating in the high end cellomics market are Thermo Fisher Scientific, Danaher, PerkinElmer, BD, Bio-Rad Laboratories, Agilent Technologies, Illumina, Luminex, Merck KGaA, GE Healthcare, Bruker, Nanostring Technologies, 10x Genomics, Fluidigm, Celsee, Berkeley Lights, Miltenyi Biotec, Bionano Genomics, Bio-Techne, Sphere Fluidics.